Foam preparations for the treatment of ulcerative colitis

Current Drug Delivery

Volumn 9, Issue 4, 2012, Pages 338-344

  Loew, Burr J ^a   Siegel, Corey A ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

5 aminosalicylic acid; Corticosteroids; Enemas; Foam preparations; Proctitis; Systematic review; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; BUDENOFALK; BUDESONIDE; ENEMA; FOAMING AGENT; HYDROCORTISONE; HYDROCORTISONE ACETATE; MESALAZINE; PLACEBO; PREDNISOLONE; PROCTOFAOM; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; COLON DISEASE; COLON MUCOSA; DIARRHEA; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TOLERABILITY; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; MONOTHERAPY; NAUSEA; PATIENT PREFERENCE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROCTOSIGMOIDITIS; QUALITY OF LIFE; REVIEW; SAFETY; SIGMOID; SUPPOSITORY; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

EID: 84863537183     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720112801323062     Document Type: Review

References (26)

1. Osterman, M.T.; Lichtenstein, G.R. In: Feldman, Friedman, Brandt, eds: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 9th ed. Saunder Elsevier: Philadelphia, PA, 2010, pp. 1975-2012.
2. Marshall, J.K.; Irvine, E.J. Putting rectal 5-aminosalicylic acid in its place: The role in distal ulcerative colitis. Am. J. Gastroenterol., 2000, 95, 1628-1636.
3. Dilger, K.; Trenk, D.; Rossle, M.; Cap, M.; Zähringer, A.; Wacheck, V.; Remmler, C.; Cascorbi, I.; Kreisel, W.; Novacek, G. A clinical trial on absorption and N-acetylation of oral and rectal mesalazine. Eur. J. Gastroenterol. Hepatol., 2007, 37, 558-565.
4. Marshall, J.K.; Irvine, E.J. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut, 1997, 40, 775-781.
5. Campieri, M.; Corbelli, C.; Gionchetti, P.; Brignola, C.; Belluzzi, A.; Di Febo, G.; Zagni, P.; Brunetti, G.; Miglioli, M.; Barbara, L. Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Dig. Dis. Sci.,1992, 37, 1890-1897.
6. Brown, J.; Haines, S.; Wilding, I.R. Colonic spread of three rectally administered mesalazine (Pentasa) dosage forms in healthy volunteers as assessed by gamma scintigraphy. Alim. Pharmacol. Ther., 1997, 11, 685-691.
7. Wilding, I.R.; Kenyon, C.J.; Chauhan, S.; Hooper, G.; Marshall, S.; McCracken, J.S.; Staab, H.J.; Armbrecht, J. Colonic spreading of a non-chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis. Ailm. Pharmacol. Ther., 1995, 9, 161-166.
8. Pokrotnieks, J.; Marlicz, K.; Paradowski, L.; Margus, B.; Zaborowski, P.; Greinwald, R. Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study. Alim. Pharmacol. Ther., 2000, 14, 1191-1198.
9. Campieri, M.; Paoluzi, P.; D'Albasio, G.; Brunetti, G.; Pera, A.; Barbara, L. Better quality of therapy with 5-asa colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-asa enema. Dig. Dis. Sci., 1993, 38, 1843-1850.
10. Malchow, H.; Gertz, B.; The Clafoam study group. A new mesalazine foam enema (Claversal foam) compared with a standard liquid enema in patients with active distal ulcerative colitis. Alim. Pharmacol. Ther., 2002, 16, 415-423.
11. Lee, F.I.; Jewell, D.P.; Mani, V.; Keighley, M.R.; Kingston, R.D.; Record, C.O.; Grace, R.H.; Daniels, S.; Patterson, J.; Smith, K. A randomized trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Gut, 1996, 38, 229-233.
12. Cortot, A.; Maetz, D.; Degoutte, E.; Delette, O.; Meunier, P.; Tan, G.; Cazals, J.B.; Dewit, O.; Hebuterne, X.; Beorchia, S.; Grunberg, B.; Leprince, E.; D'Haens, G.; Forestier, S.; Idier, I.; Lémann, M. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis. Am. J. Gastroenterol., 2008, 103, 3106-3114.
13. Eliakim, R.; Tulassay, Z.; Kupcinskas, L.; Adamonis, K.; Pokrotnieks, J.; Bar-Meir, S.; Lavy, A.; Mueller, R.; Greinwald, R.; Chermesh, I.; Gross, V. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis. Alim. Pharmacol. Ther., 2007, 26, 1237-1249.
14. Connolly, M.P.; Poole, C.D.; Currie, C.J.; Marteau, P.; Nielsen, S.K. Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis. Digest., 2009, 80, 241-246.
15. Ruddell, W.S.; Dickinson, R.J.; Dixon, M.F.; Axon, A.T. Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut, 1980, 21, 885-889.
16. Gross, V.; Bar-Meir, S.; Lavy, A.; Mickisch, O.; Tulassay, Z.; Pronai, L.; Kupcinskas, L.; Kiudelis, G.; Pokrotnieks, J.; Kovács, A.; Faszczyk, M.; Razbadauskas, A.; Margus, B.; Stolte, M.; Müller, R.; Greinwald, R. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis. Alim. Pharmacol. Ther., 2006, 23, 303-312.
17. Bar-Meir, S.; Fidder, H.; Faszczyk, M.; Bianchi Porro, G.; Sturniolo, G.C.; Mickisch, O.; Müller, R.; Greinwald, R.; Chowers, Y.; Grobeta, V. Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis. Dis. Colon Rectum, 2003, 46, 929-936.
18. Hammond, A.; Andrus, T.; Gierend, M.; Ecker, K.W.; Scholmerich, J.; Herfarth, H. Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis. Hepato-Gastroenterol.,2004, 51, 1345-1349.
19. Brogden, R.N.; Heel, R.C.; Speight, T.M. Beclomethasone dipropionate: a reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs, 1984, 28, 99-126.
20. Busse W.W. What role for inhaled steroids in chronic asthma? Chest, 1993, 104, 1565-1571.
21. Mulder, C.J.; Fockens, P.; Meijer, J.W.; van der Heide, H.; Wiltink, E.H.; Tytgat, G.N. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (2 mg/2 g) as retention enemas in active ulcerative proctitis. Eur. J. Gastroenterol., Hepatol., 1996, 8, 549-553.
22. Biancone, L.; Gionchetti, P.; Del Vecchio Blanco, G.; Orlando, A.; Annese, V.; Papi, C.; Sostegni, R.; D'Incà, R.; Petruzziello, C.; Casa, A.; Sica, G.; Calabrese, E.; Campieri, M.; Pallone, F. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. Digest. Liver Dis., 2007, 39, 329-337.
23. Manguso, F.; Balzano, A. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis. Alim. Pharmacol. Ther., 2007, 26, 21-29.
24. Van Os, E.C.; Zins, B.J.; Sandborn, W.J.; Mays, D.C.; Tremaine, W.J.; Mahoney, D.W.; Zinsmeister, A.R.; Lipsky, J.J. Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal formulations. Gut, 1996, 39, 63-68.
25. Kane, S.V.; Cohen, R.D.; Aikens, J.E.; Hanauer, S.B. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am. J. Gastroenterol., 2001, 96, 2929-2933.
26. Cohen, R.D.; Woseth, D.M.; Thisted, R.A.; Hanauer, S.B. A metaanalysis and overview of the literature on treatment options for leftsided ulcerative colitis and ulcerative proctitis. Am. J. Gastroenterol., 2000, 95, 1263-1276.